Skip to content

Free Light Chain Immunoglobulin (Serum)

Published: August 9, 2026Updated: August 16, 2026

This test measures the free light chains (kappa and lambda) produced by your immune system’s B cells. These fragments can help detect certain conditions affecting the blood or immune system.

Quick summary

["This test helps identify abnormal light chain production that may signal multiple myeloma or other blood disorders."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
95800-9
Short code
Immunoglobulin LC free Pnl Ur
Synonyms
Immunoglobulin LC free Pnl Ur
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your doctor may order this test if you have symptoms like unexplained fatigue, frequent infections, or kidney problems. It’s also used to monitor conditions like multiple myeloma, where abnormal plasma cells produce too many light chains.

What to Expect Before the Test

No special preparation is needed. You’ll have a small needle inserted into your arm or vein to draw blood. If you’re nervous, let your healthcare provider know—they can help make it more comfortable.

What the Results Mean

High levels of free light chains may indicate conditions like multiple myeloma, lymphoma, or kidney disease. Low levels are less common but could suggest immune system issues. Your doctor will compare your results to your medical history and other tests.

Common Conditions Monitored

This test is often used to diagnose or track multiple myeloma, a cancer of plasma cells, or to check for other blood disorders like Waldenström macroglobulinemia or certain lymphomas.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Free light chains are normally balanced in the body. When they’re produced in excess (often due to plasma cell disorders), they can clog kidneys or cause other complications. Elevated levels can signal cancer or immune system dysfunction, prompting further testing or treatment adjustments.

Short name

Free Light Chain Test

Frequently asked questions

What causes abnormal free light chain levels?
Abnormal levels are most commonly linked to multiple myeloma, where plasma cells overproduce light chains. Other conditions, such as certain lymphomas, kidney disease, or autoimmune disorders, may also affect these levels.
How are free light chains different from total immunoglobulins?
Free light chains are the small protein fragments released when antibodies break down. Unlike total immunoglobulins (which include bound and free chains), free light chains are measured separately to detect imbalances in plasma cell disorders.
Can diet or medications affect free light chain test results?
Dietary changes or most over-the-counter medications typically don’t affect this test. However, certain medications (like chemotherapy or steroids) used to treat blood disorders may influence results, so discuss this with your doctor.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy